Latest news
Multidisciplinary Co-Management of Patients Receiving Radioligand Therapy - Phillip Koo & Neha Vapiwala - UroTodayUroToday · Fri, 07 Aug 2026 22:29:26 GMTPSMA PET Interpretation in Biochemical Recurrence After Prostate Cancer Treatment - Steve Cho - UroTodayUroToday · Fri, 07 Aug 2026 21:54:26 GMTAccel-KKR, Bain, Knox Lane bet on clinical workforce services; Tech advances drive Nordic’s $800m take-private of BWXT’s nuclear med biz - pehub.compehub.com · Fri, 07 Aug 2026 09:50:17 GMTRadiopharmaceutical May Benefit Patients with Metastatic Prostate Cancer Sooner - WCM NewsroomWCM Newsroom · Thu, 06 Aug 2026 22:47:14 GMTLantheus reports increased Q2 revenues following Curium transaction - AuntMinnieAuntMinnie · Thu, 06 Aug 2026 18:16:54 GMTShared cardiac PET programs can expand access while controlling costs - Cardiovascular BusinessCardiovascular Business · Thu, 06 Aug 2026 16:08:38 GMTOntario invests in medical radioisotope production at McMaster - ans.organs.org · Thu, 06 Aug 2026 13:09:17 GMTWhat Does the Curium Transaction Mean for Lantheus Holdings (NASDAQ:LNTH) and Nuclear Medicine? - kalkinemedia.comkalkinemedia.com · Wed, 05 Aug 2026 19:30:00 GMT